TSPY1 and neoplasm: These findings collectively suggested that both humoral and cellular immune responses, and likely other immune processes e.g. M1 macrophage and innate immune NK cells, were activated in the immune elimination of TSPY-positive tumor cells at the early stage of hepatocarcinogenesis.